1. Bennett, S. The role of community-based health insurance within the health care financing system: A framework for analysis. Health Policy Plan. 2004;19:147–158.
2. Carrin, G, Waelkens, MP, Criel, B. Community-based health insurance in developing countries: A study of its contribution to the performance of health financing systems. Trop Med Int Health. 2005;10:799–811.
3. Clinton Foundation. Distribution of artemisinin-based combination therapies through private sector channels: Lessons from four country case studies. New York: Clinton Foundation; 2008.
4. Ekman, B. Community-based health insurance in low-income countries: A systematic review of the evidence. Health Policy Plann. 2004;19:249–270.
5. Fapohunda, BM, Beth, AP, Robert, A, et al. Home-based management of fever strategy in Uganda: A report of the 2003 survey. Arlington, VA: MOH, WHO and BASICS II; 2004.
6. Goodman, CA. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. Thesis submitted to the University of London for the Degree of Doctor of Philosophy. London: London School of Hygiene and Tropical Medicine, Health Policy Unit; 2004.
7. Grilli, R, Ramsay, C, Minozzi, S. Mass media interventions: Effects on health services utilisation. Cochrane Database Syst Rev. 2002;(1);1:CD000389.
8. Ikeoluwapo, OA, Browne, EN, Garshong, B, et al. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malaria J. 2008;7:6.
9. Kutzin, J, Barnum, H. How health insurance affects the delivery of health care in developing countries. World Bank technical paper. Washington DC: World Bank; 1992.
10. Lagaarde, M, Palmer, N. Evidence from systematic reviews to inform decision making regarding financing mechanisms that improve access to health services for poor people. A policy brief prepared for the International Dialogue on Evidence-Informed Action to Achieve Health Goals in Developing Countries (IDEAHealth). Geneva: Alliance for Health Policy and Systems Research; 2006. http://www.who.int/rpc/meetings/HealthFinancingBrief.pdf. (accessed February 28, 2008) 11. Lewin, SA, Babigumira, SM, Bosch-Capblanch, X, et al. Lay health workers in primary and community health care: A systematic review of trials. Geneva: Alliance for Health Policy and Systems Research; 2006. www.who.int/rpc/meetings/LHW_review.pdf. (accessed December 24, 2009)
12. Ministry of Health. Antimalarial treatment policy change to ACTs. Kampala, Uganda: Ministry of Health; 2005.
13. Ministry of Health. Management of uncomplicated malaria. A practical guide for health workers. 3rd ed. Kampala, Uganda: Ministry of Health Malaria Control Programme; 2005.
14. Ministry of Health. National guidelines for treatment. Diagnosis and prevention of malaria in Kenya. Nairobi, Kenya: Ministry of Health; 2006.
15. Ministry of Health. The guidelines for malaria diagnosis and treatment. Zanzibar: United Republic of Tanzania: Ministry of Health; 2007.
16. Ranson, MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: Current experiences and challenges. Bull World Health Organ. 2002;80:613–621.
17. Samarasekera, U. Drug subsidy could help Tanzania tackle malaria. Lancet. 2008;371:1403–1406.
18. Waters, H, Hatt, L, Peters, D. Working with the private sector for child health. Health Policy Plan. 2003;18:127–137.
19. World Health Organization. Antimalarial drug combination therapy. Report of a WHO technical consultation. Geneva, Switzerland: World Health Organization; 2001.
21. World Health Organization. Guidelines for the treatment of malaria. Geneva, Switzerland: World Health Organization; 2006.
22. World Health Organization. The use of artemisinin and its derivatives as antimalarial drugs: A report of a joint CTD/DMP/TDR Informal Consultation. Geneva: World Health Organization; 1998. WHO/MAL/98.1086
23. World Health Organization. World malaria report 2008. Geneva: Global Malaria Programme; 2008. WHO/HTM/GMP/2008.
24. Yeboah-Antwi, K, Gyapong, JO, Asare, IK, et al. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ. 2001;79:394–399.